| Full Name | Subba Raju |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 38 Years |
| Location | 934 Center St, Elgin, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427019546 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Advocate Sherman Hospital | Elgin, IL | Hospital |
| Advocate Lutheran General Hospital | Park ridge, IL | Hospital |
| Presence Saint Joseph Hospital - Elgin | Elgin, IL | Hospital |
| Central Dupage Hospital | Winfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integrated Imaging Consultants Llc | 2567784408 | 166 |
News Archive
Competing cardiac care teams in some of the nation's most populated areas will start working together to markedly reduce the time from heart attack to treatment as part of a new program designed by cardiologists at Duke University Medical Center.
The study, which looked at 120 people over the age of 60, found people who complained of significant memory problems but still had normal performance on memory tests had reduced gray matter density in their brains even though they weren't diagnosed with Alzheimer's disease or mild cognitive impairment (MCI).
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 2 days ago
| Entity Name | Integrated Imaging Consultants Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700285335 PECOS PAC ID: 2567784408 Enrollment ID: O20141204001441 |
News Archive
Competing cardiac care teams in some of the nation's most populated areas will start working together to markedly reduce the time from heart attack to treatment as part of a new program designed by cardiologists at Duke University Medical Center.
The study, which looked at 120 people over the age of 60, found people who complained of significant memory problems but still had normal performance on memory tests had reduced gray matter density in their brains even though they weren't diagnosed with Alzheimer's disease or mild cognitive impairment (MCI).
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Subba Raju, MD 34659 Eagle Way, Chicago, IL 60678-1346 Ph: (847) 676-0091 | Subba Raju, MD 934 Center St, Elgin, IL 60120-2125 Ph: (847) 429-8998 |
News Archive
Competing cardiac care teams in some of the nation's most populated areas will start working together to markedly reduce the time from heart attack to treatment as part of a new program designed by cardiologists at Duke University Medical Center.
The study, which looked at 120 people over the age of 60, found people who complained of significant memory problems but still had normal performance on memory tests had reduced gray matter density in their brains even though they weren't diagnosed with Alzheimer's disease or mild cognitive impairment (MCI).
Epeius Biotechnologies Corporation, an emerging leader in the field of targeted genetic medicine, received a notice of allowance from the USPTO for a crucial patent covering its leading tumor-targeted vaccine technology for cancer immunotherapy. The issuance of this valuable patent protection for tumor targeted immunotherapy follows on the heels of two international patents covering targeted gene medicine in the U.S. and Europe, respectively, and places Epeius Biotech at the forefront of these emerging fields of clinical medicine with best-of-breed solutions and incontrovertible proofs-of-principle in the clinic.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc. – Florida, has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem Hydrochloride Extended-Release tablets, the generic equivalent to Biovail Laboratories International SRL's Cardizem® LA product. Watson intends to launch its generic version of Cardizem® LA immediately.
› Verified 2 days ago
Jeffrey P Shafer, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 77 N Airlite Street, Elgin, IL 60123 Phone: 847-931-5520 Fax: 847-695-3319 | |
Brian Schwartz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 77 N Airlite St, Elgin, IL 60123 Phone: 847-695-3200 Fax: 847-695-8815 | |
Gongyu Yang, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1425 N Randall Rd, Elgin, IL 60123 Phone: 847-429-8998 | |
Rotimi Johnson, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2385 Bowes Rd Ste 350, Elgin, IL 60123 Phone: 847-429-2091 Fax: 847-429-2440 | |
Amitabh Singh, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 934 Center St, Elgin, IL 60120 Phone: 847-429-8998 | |
Michael J Smith, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1425 N Randall Rd, Elgin, IL 60123 Phone: 224-783-6873 | |
Lee Green, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 934 Center St, Elgin, IL 60120 Phone: 847-429-8998 |